[Infectious complications of lymphedema].
Identifieur interne : 004510 ( PubMed/Curation ); précédent : 004509; suivant : 004511[Infectious complications of lymphedema].
Auteurs : L. Vaillant [France] ; N. GironetSource :
- La Revue de medecine interne [ 0248-8663 ] ; 2002.
Descripteurs français
- KwdFr :
- MESH :
- microbiologie : Lymphoedème.
- usage thérapeutique : Pénicillines.
- étiologie : Lymphangite, Érysipèle.
- Antibioprophylaxie, Facteurs de risque, Humains, Lymphoedème, Techniques de physiothérapie.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Penicillins.
- complications : Lymphedema.
- etiology : Erysipelas, Lymphangitis.
- microbiology : Lymphedema.
- Antibiotic Prophylaxis, Humans, Physical Therapy Modalities, Risk Factors.
Abstract
Erysipelas and lymphangitis are frequent complications of lymphedemas (20 to 30%). The most important risk factor for erysipelas is lymphedema since this is a protein rich edema that contributes to the risk of infection. In case of lymphedema the treatment is the usual consensus treatment for erysipelas. A prophylactic treatment with penicillin is requested as soon as the first recurrence. This prophylactic treatment includes skin care, particularly treatment of injuries and intertrigos. Hyperplastic skin leads to maceration and then mycoses. Physiotherapy does not increase the risk for infection. Moreover an infection needs a complex decongestive physiotherapy which decreases risks of recurrence.
PubMed: 12162204
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004510
Links to Exploration step
pubmed:12162204Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Infectious complications of lymphedema].</title>
<author><name sortKey="Vaillant, L" sort="Vaillant, L" uniqKey="Vaillant L" first="L" last="Vaillant">L. Vaillant</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de dermatologie et unité de lymphologie, hôpital Trousseau, CHRU, 37044 Tours, France. vaillant@med.univ-tours.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de dermatologie et unité de lymphologie, hôpital Trousseau, CHRU, 37044 Tours</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gironet, N" sort="Gironet, N" uniqKey="Gironet N" first="N" last="Gironet">N. Gironet</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12162204</idno>
<idno type="pmid">12162204</idno>
<idno type="wicri:Area/PubMed/Corpus">004510</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004510</idno>
<idno type="wicri:Area/PubMed/Curation">004510</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004510</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Infectious complications of lymphedema].</title>
<author><name sortKey="Vaillant, L" sort="Vaillant, L" uniqKey="Vaillant L" first="L" last="Vaillant">L. Vaillant</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de dermatologie et unité de lymphologie, hôpital Trousseau, CHRU, 37044 Tours, France. vaillant@med.univ-tours.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de dermatologie et unité de lymphologie, hôpital Trousseau, CHRU, 37044 Tours</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gironet, N" sort="Gironet, N" uniqKey="Gironet N" first="N" last="Gironet">N. Gironet</name>
</author>
</analytic>
<series><title level="j">La Revue de medecine interne</title>
<idno type="ISSN">0248-8663</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibiotic Prophylaxis</term>
<term>Erysipelas (etiology)</term>
<term>Humans</term>
<term>Lymphangitis (etiology)</term>
<term>Lymphedema (complications)</term>
<term>Lymphedema (microbiology)</term>
<term>Penicillins (therapeutic use)</term>
<term>Physical Therapy Modalities</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antibioprophylaxie</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Lymphangite (étiologie)</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (microbiologie)</term>
<term>Pénicillines (usage thérapeutique)</term>
<term>Techniques de physiothérapie</term>
<term>Érysipèle (étiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Penicillins</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Erysipelas</term>
<term>Lymphangitis</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Pénicillines</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphangite</term>
<term>Érysipèle</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Antibiotic Prophylaxis</term>
<term>Humans</term>
<term>Physical Therapy Modalities</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Antibioprophylaxie</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Techniques de physiothérapie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Erysipelas and lymphangitis are frequent complications of lymphedemas (20 to 30%). The most important risk factor for erysipelas is lymphedema since this is a protein rich edema that contributes to the risk of infection. In case of lymphedema the treatment is the usual consensus treatment for erysipelas. A prophylactic treatment with penicillin is requested as soon as the first recurrence. This prophylactic treatment includes skin care, particularly treatment of injuries and intertrigos. Hyperplastic skin leads to maceration and then mycoses. Physiotherapy does not increase the risk for infection. Moreover an infection needs a complex decongestive physiotherapy which decreases risks of recurrence.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12162204</PMID>
<DateCreated><Year>2002</Year>
<Month>08</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted><Year>2002</Year>
<Month>09</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>10</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0248-8663</ISSN>
<JournalIssue CitedMedium="Print"><Volume>23 Suppl 3</Volume>
<PubDate><Year>2002</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>La Revue de medecine interne</Title>
<ISOAbbreviation>Rev Med Interne</ISOAbbreviation>
</Journal>
<ArticleTitle>[Infectious complications of lymphedema].</ArticleTitle>
<Pagination><MedlinePgn>403s-407s</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Erysipelas and lymphangitis are frequent complications of lymphedemas (20 to 30%). The most important risk factor for erysipelas is lymphedema since this is a protein rich edema that contributes to the risk of infection. In case of lymphedema the treatment is the usual consensus treatment for erysipelas. A prophylactic treatment with penicillin is requested as soon as the first recurrence. This prophylactic treatment includes skin care, particularly treatment of injuries and intertrigos. Hyperplastic skin leads to maceration and then mycoses. Physiotherapy does not increase the risk for infection. Moreover an infection needs a complex decongestive physiotherapy which decreases risks of recurrence.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaillant</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Service de dermatologie et unité de lymphologie, hôpital Trousseau, CHRU, 37044 Tours, France. vaillant@med.univ-tours.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gironet</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Complications infectieuses des lymphoedèmes.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Rev Med Interne</MedlineTA>
<NlmUniqueID>8101383</NlmUniqueID>
<ISSNLinking>0248-8663</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010406">Penicillins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D019072" MajorTopicYN="Y">Antibiotic Prophylaxis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004886" MajorTopicYN="N">Erysipelas</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008205" MajorTopicYN="N">Lymphangitis</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010406" MajorTopicYN="N">Penicillins</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D026741" MajorTopicYN="N">Physical Therapy Modalities</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>21</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2002</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2002</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12162204</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004510 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 004510 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:12162204 |texte= [Infectious complications of lymphedema]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:12162204" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |